More

    Finance

    The Fed probably won’t deliver any interest rate cuts this summer

    Traders work on the floor of the New York Stock Exchange during morning trading on May 24, 2024 in New York City. Michael M....

    Explainer-What does Louisiana’s new abortion pill law mean for patients? By Reuters

    By Ahmed Aboulenein and Brendan Pierson (Reuters) - The Louisiana Senate's vote on Thursday to reclassify the two drugs used in medication...

    G7 agree further financing for Ukraine, to discuss details in coming weeks By Reuters

    STRESA, ITALY (Reuters) - Finance ministers from the Group of Seven wealthy democracies have agreed on further financing for Ukraine but have...

    Investors in Sprout Social that Lost Money when Stock Tumbled 40% Are Encouraged to Contact BFA Law by July Deadline in Class Action Lawsuit...

    NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 12, 2024 deadline...

    In restive New Caledonia, Macron sees Pacific power and influence By Reuters

    By Layli Foroudi and Juliette Jabkhiro PARIS (Reuters) - In 2018, a year after becoming France's president, Emmanuel Macron flew to the...

    US asset prices are rising despite falling money supply By Investing.com

    Gavekal Research strategists highlighted the unusual trend of US asset prices climbing despite a contraction in money supply, a divergence from the typical...

    Biden set to deliver commencement at West Point on Saturday By Reuters

    By Jarrett Renshaw WILMINGTON, Delaware (Reuters) - U.S. President Biden will deliver the commencement speech on Saturday at the U.S. Military Academy...

    Four years after George Floyd killing, police reform slow to follow By Reuters

    By Bianca Flowers and Stephanie Kelly (Reuters) - Stevante Clark felt a glimmer of hope when racial justice protests swept the globe...

    Novartis presents latest Phase III Fabhalta ® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo

    Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be...

    Latest articles

    spot_imgspot_img